Nasal polyp surgery removes noncancerous growths from your nasal and sinus passageways. In the weeks following surgery, you may notice slight bleeding from your nose and crusts. It’s common for polyps ...
SAN DIEGO -- Tezepelumab (Tezspire) reduced nasal polyps and symptoms in severe chronic rhinosinusitis while also decreasing need for further treatments, the WAYPOINT trial showed. The monoclonal ...
Surgery is the only way to fully remove a nasal polyp, but they can still regrow. Prescription nasal sprays and oral medications can help to shrink nasal polyps without the need for surgery. Nasal ...
Please provide your email address to receive an email when new articles are posted on . A greater proportion of patients with severe chronic rhinosinusitis with nasal polyps who received mepolizumab ...
Tezepelumab (Tezspire) has shown significant clinical benefits in adults with severe chronic rhinosinusitis with nasal polyps (CRSwNP), including marked reductions in nasal congestion and polyp size ...
TUESDAY, May 6, 2025 (HealthDay News) -- For patients with chronic sinusitis and nasal polyps, nasal endoscopic surgery can remove polyps in a shorter time, with less intraoperative blood loss ...
Hosted on MSN
Monoclonal antibody significantly reduces nasal polyps and need for surgery in Phase 3 clinical trial
Chronic rhinosinusitis with nasal polyps presents a substantial clinical burden, affecting nasal airflow, olfactory function, and quality of life. Epithelial barrier dysfunction and type 2 ...
Antrochoanal polyps (ACPs) are benign, solitary lesions that originate from the mucosa of the maxillary sinus and extend into the nasal cavity towards the choana. They can present with unilateral ...
Please provide your email address to receive an email when new articles are posted on . Twelve-year data were available for 71 patients, or 85.5% of the assessed study population. Around 55% of those ...
The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on antibiotics at the time of their initial surgery. However, higher age was ...
For severe chronic rhinosinusitis with nasal polyps, the novel monoclonal antibody stapokibart reduced symptoms and polyp size atop treatment with a daily intranasal corticosteroid. The polyp size ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback